BMRNBioMarin PharmaceuticalHealth Care
$57.29EarningsAug 3, 2026
1D—1W—1M—3M—1Y—
Market cap$11.3BCompany infoRevenue$3.2B52-wk range$50 – $64IndustryBiotechnologyWebsitebiomarin.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +4.8% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E41.2×2221
16
966
P / S3.5×4051
3
9
P / FCF14.8×6473
13
868
EV / EBITDA21.8×2324
11
343
P / E (fwd)11.6×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin75.9%8880
71%
81%
Operating margin13.6%4345
-4%
25%
Net margin8.3%4144
-3%
44%
ROE4.5%1929
-2%
20%
ROIC4.0%2027
-1%
9%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.237767
0.1
0.3
Net debt / EBITDA-1.6×8887
Current ratio5.819492
Interest coverage19.1×7773
Per shareTTM, with year-over-year change
Revenue / share$16.40▲ +10%
EPS (diluted)$1.39▼ −48%
FCF / share$3.88▲ +24%
Est. EPS growth (fwd)+33%